Banti Pharma Private Limited
About Banti Pharma Private Limited
Data last updated:
Banti Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC390347. Its GSTIN is 07AAKCB3274C1ZV (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nikhil Kumar Burnwal and Manish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sl – 10 L Block, Hari Nagar, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.15 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹87,696 (net margin 0.1%) and EBITDA of ₹2.58 Lakh (EBITDA margin 0.2%).
Company details
Contact details
Banti Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressSl – 10 L Block, Hari Nagar, New Delhi, Delhi, India – 110064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Banti Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Banti Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Banti Pharma Private Limited, buy the company report.
Financials of Banti Pharma Private Limited
FY 2025 filings availableBanti Pharma Private Limited reported revenue of ₹12.15 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year. EBITDA rose 28% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.58 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹87,696 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.2% | ||
| Net Profit Margin | 0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Banti Pharma Private Limited, buy the company report.
Board of directors of Banti Pharma Private Limited
Banti Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Kumar Burnwal | Director | 24 Nov 2021 | 4 Years 11 Months | Current |
| Manish Kumar | Director | 24 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Banti Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stuve Coremin Private Limited | ₹12.27 Cr (FY 2025) | -77.0% | Mumbai, Maharashtra, India | |||
| STL Transworld Private Limited | ₹12.27 Cr (FY 2025) | 48.0% | Thane, Maharashtra, India | |||
| Av Finvest Unicorn Private Limited | ₹12.26 Cr (FY 2025) | 554.0% | Kolkata, West Bengal, India | |||
| Novelvet Farmsolutions Private Limited | ₹12.23 Cr (FY 2025) | 20.0% | Pune, Maharashtra, India | |||
| Mado Retails Private Limited | ₹12.18 Cr (FY 2024) | Sankrail, West Bengal, India | ||||
| Banti Pharma Private Limitedthis company | ₹12.15 Cr (FY 2024) | ₹87,696 | 0.1% | -11.0% | New Delhi, Delhi, India | |
| Ambaty Silks Private Limited | ₹12.13 Cr (FY 2025) | 43.0% | Nuzvid, Andhra Pradesh, India | |||
| Haritha Bio and Infra Private Limited | ₹12.11 Cr (FY 2025) | 26.0% | Bangalore, Karnataka, India | |||
| 7Gem Private Limited | ₹12.1 Cr (FY 2024) | 765.0% | New Delhi, Delhi, India | |||
| Subhsansar Corporation Private Limited | ₹12.08 Cr (FY 2025) | 674.0% | Utraula, Uttar Pradesh, India | |||
| Effulgence Forex Private Limited | ₹12.08 Cr (FY 2024) | -50.0% | Delhi, India |
To see the full peer comparison of Banti Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Banti Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Banti Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Banti Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Banti Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCB3274C1ZV | Delhi | Active | 05 Dec 2021 |
To see the full GST registrations and return filing status of Banti Pharma Private Limited, buy the company report.
Recent activity
Banti Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Ravinder Singh ceased to be Director on 15 Jul 2022.
Frequently asked questions
Banti Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 November 2021 (5+ years old) and is registered under CIN U51909DL2021PTC390347.
Banti Pharma has 2 current directors:
- Nikhil Kumar Burnwal - Director
- Manish Kumar - Director
The latest financial statements of Banti Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Banti Pharma is 07AAKCB3274C1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Banti Pharma is U51909DL2021PTC390347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Banti Pharma was incorporated on 24 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Banti Pharma by revenue are Stuve Coremin Private Limited, STL Transworld Private Limited, Av Finvest Unicorn Private Limited, Novelvet Farmsolutions Private Limited, Mado Retails Private Limited and 5 more, all in the same principal business activity (retail trade, except of motor vehicles and motorcycles).
Ravinder Singh ceased to be Director on 15 Jul 2022. Manish Kumar was appointed as Director on 24 Nov 2021. Nikhil Kumar Burnwal was appointed as Director on 24 Nov 2021.
The registered office of Banti Pharma is at Sl – 10 L Block, Hari Nagar, New Delhi, Delhi, India – 110064.
Banti Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Banti Pharma can be reached at its registered office: Sl – 10 L Block, Hari Nagar, New Delhi, Delhi, India – 110064.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
